Please assess the completion status of the following clinical trial:

Trial Title: Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of NAFLD and/or NASH~* Subject aged 18 and older~* Non-pregnant - Self-reported~* Subject with decision making capacity to understand and consent to study procedures~* Ability to follow study related activities regarding medications, diet and exercise~Exclusion Criteria:~* Without diagnosis of NAFLD or NASH~* History of liver disease from other causes, including but not limited to hepatitis, autoimmune, alcohol use, fatty liver of pregnancy, Wilson's disease, primary or secondary hemochromatosis~* Patients aged less than 18 years~* Self-reported pregnant patients~* Inability to understand, follow and consent to study procedures~* Hepatic decompensation defined as gastrointestinal bleeding, ascites, hepatic encephalopathy~* Inability to engage in exercise~* Currently immunocompromised or taking immunosuppressive drugs~* Milk protein allergy~* Recent or active chemotherapy for malignancy~* Gastrointestinal malignancy~* Gastrointestinal disease such as Ulcerative Colitis, Crohn's Disease as these alter the microbiome~* Recent antibiotic therapy (within 6 months)~* Known allergy to probiotics~* History of major gastrointestinal surgery such as resection of the colon~* No concomitant use of probiotic from any source (i.e., kefir, certain yogurts, live culture, sauerkraut)~* Liver scan \>2 months prior to enrollment~* Weight loss \>5 pounds in the last 2 months~* Any implanted battery operated device (i.e. AICD, pacemaker, loop recorder, cochlear implant)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Treatment Group: Probiotic (Type: ACTIVE_COMPARATOR): Probiotic 1 billion units Supplement Once Daily
- Control Group: Placebo (Type: PLACEBO_COMPARATOR): Placebo Capsule Once Daily

Based on this trial design, predict the completion outcome and termination type (if applicable).